Stocks Fueled on Strong Profitability (TROX, CELG, PLSB, ATI)

Los Angelas, CA -- (SBWIRE) -- 11/13/2012 -- Tronox Limited (NYSE:TROX) today reported revenue of $487.3 million in the third quarter, up 5 percent versus revenue of $465.4 million in the third quarter of 2011. The current quarter includes $216.1 million of revenue from acquired business. Adjusted EBITDA was $131.1 million in the third quarter, compared to adjusted EBITDA of $140.9 million in the year-ago quarter. The current quarter includes $106.8 million of adjusted EBITDA from acquired business. Included in current quarter earnings is $85.2 million of net amortization related to the fair value step-up of inventory and unfavorable feedstock sales contracts, primarily associated with the mineral sands acquisition. The company reported a net loss of $16.7 million, $0.14 per diluted share in the third quarter 2012. Adjusted net income in the current quarter was $25.6 million, or $0.21 per diluted share, versus $1.45 per diluted share in the third quarter 2011. Adjusted earnings per diluted share in the current quarter are based on 122.4 million fully diluted shares outstanding versus 79.2 million fully diluted shares outstanding in the year-ago quarter.

Collect The Full Research Report On TROX For Free: CLICK HERE

Celgene Corporati (NASDAQ:CELG) is +4.16 - +5.82% from the previous close of $71.50. It traded between $74.30 - 78.46 with total traded volume of 7527481 shares. At Current Market Price, CELG is in distance of -1.66% from its 50-day Moving Average price of $76.9374 and +6.39% from its 200-day Moving Average price of $71.1134. Celgene Corp. CELG +5.82% shares closed up nearly 6%. A late-stage study of the company’s Abraxane drug significantly improved the life spans of patients with pancreatic cancer, one of the deadliest and hardest-to-treat diseases, according to Celgene. The combination therapy under study showed a statistically significant improvement in overall survival, meeting the primary endpoint, the company said, although it didn’t report a specific number.

Should Investor Hold or Exit From CELG: CHECK NOW FOR FREE

The Pulse Beverage Corporation (PINK:PLSB) ("Pulse" or the "Company"), makers of the PULSE® brand of "good-for-you" NutriPurpose™ beverages today announced that on the heels of its recently announced agreement to distribute the Cabana™ brand Lemonades with K&G Distribution (Jenny's Markets, KG Conoco), the Company wishes to announce the appointment of veteran industry sales manager Parley (Paddy) Sheya as a director of the Company. Bob Yates, CEO of Pulse, comments, "We have been formalizing final contracts with numerous major distributors that supply the Western US as well as Internationally in Canada, Africa, the Philippines and Taiwan; the demand is such that we anticipate selling out our first 50,000 cases of production. This is based on the commitments we have received from distributors and grocery wholesalers; both Paddy and I are very pleased by this initial success. Needless to say, I am also extremely pleased to welcome his appointment to the Company's Board."

How Should Investors React to PLSB Now? Find Out Here

Allegheny Technologies (NYSE:ATI) is one of the companies pushing the Industrial Goods sector higher today. As of noon trading, Allegheny Technologies is up $1.47 (5.5%) to $28.24 on average volume Thus far, 944,273 shares of Allegheny Technologies exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $27.31-$28.30 after having opened the day at $27.73 as compared to the previous trading day's close of $26.77.

Allegheny Technologies Incorporated (ATI) engages in the production of specialty metals worldwide. It operates in three segments: High Performance Metals, Flat-Rolled Products, and Engineered Products. Allegheny Technologies has a market cap of $2.9 billion and is part of the industrial industry. The company has a P/E ratio of 16.6, below the S&P 500 P/E ratio of 17.7. Shares are down 44.2% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Allegheny Technologies a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Allegheny Technologies as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including poor profit margins, a generally disappointing performance in the stock itself and deteriorating net income.

Can ATI Touch $47.00 From Here or Going Down: Collect A Top Analyst Report From Here

Disclaimer
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com